Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Cash from Operations: 2019-2024

Historic Cash from Operations for P3 Health Partners (PIII) over the last 6 years, with FY2024 value amounting to -$110.1 million.

  • P3 Health Partners' Cash from Operations rose 3185.96% to -$15.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$99.0 million, marking a year-over-year decrease of 3573.37%. This contributed to the annual value of -$110.1 million for FY2024, which is 4485.19% down from last year.
  • As of FY2024, P3 Health Partners' Cash from Operations stood at -$110.1 million, which was down 4485.19% from -$76.0 million recorded in FY2023.
  • P3 Health Partners' 5-year Cash from Operations high stood at -$24.6 million for FY2020, and its period low was -$126.0 million during FY2022.
  • Moreover, its 5-year median value for Cash from Operations was -$76.0 million (2023), whereas its average is -$77.6 million.
  • In the last 5 years, P3 Health Partners' Cash from Operations skyrocketed by 3966.94% in 2023 and then tumbled by 4485.19% in 2024.
  • Over the past 5 years, P3 Health Partners' Cash from Operations (Annual) stood at -$24.6 million in 2020, then plummeted by 107.88% to -$51.1 million in 2021, then tumbled by 146.47% to -$126.0 million in 2022, then surged by 39.67% to -$76.0 million in 2023, then crashed by 44.85% to -$110.1 million in 2024.
  • Its Cash from Operations was -$110.1 million in FY2024, compared to -$76.0 million in FY2023 and -$126.0 million in FY2022.